Botulinum toxin in headache treatment: The end of the road?

Cephalalgia

Volumn 26, Issue 7, 2006, Pages 769-771

  Evers, S ^a   Olesen, J ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; PLACEBO; SODIUM CHLORIDE;

CHRONIC TENSION HEADACHE; DRUG EFFICACY; EDITORIAL; HEADACHE; HUMAN;

BOTULINUM TOXIN TYPE A; EVIDENCE-BASED MEDICINE; HEADACHE; HEADACHE DISORDERS; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33745087471     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01160.x     Document Type: Editorial

References (24)

1. Silberstein SD Göbel H Jensen R Elkind AH DeGryse R Walcott JMCM Turkel C. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia 2006 26 : 790 800.
2. Evers S Rahmann A Vollmer-Haase J Husstedt IW. Treatment of headache with botulinum toxin A - a review according to evidence-based medicine criteria. Cephalalgia 2002 22 : 699 710.
3. Schoenen J. Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials. Cephalalgia 1995 15 : 165 79.
4. Tfelt-Hansen P Block G Dahlöf C Diener HC Ferrari MD Goadsby PJ et al. Guidelines for controlled trials of drugs in migraine : second edition. Cephalalgia 2000 20 : 765 86.
5. Dodick DW Mauskop A Elkind AH DeGryse R Brin MF Silberstein SD. Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 2005 45 : 315 24.
6. Mathew NT Frishberg BM Gawel M Dimitrova RT Gibson J Turkel C. Botulinum toxin type A (Botox®) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 2005 45 : 293 307.
7. Göbel H Lindner V Krack P Heinze A Gaartz N Deuschl G. Treatment of chronic tension-type headache with botulinum toxin. Cephalalgia 1999 19 : 455.
8. Smuts JA Baker MK Smuts HM Stassen JMR Rossouw E Barnard PWA. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999 6 ( Suppl. 4 99 102.
9. Rollnik JD Tanneberger O Schubert M Schneider U Dengler R. Treatment of tensiontype headache with botulinum toxin A: a double-blind, placebo-controlled study. Headache 2000 40 : 300 5.
10. Silberstein S Mathew N Saper J Jenkins S. Botulinum toxin type A as a migraine preventive treatment. Headache 2000 40 : 445 50.
11. Brin MF Swope DM O'Brien C Abbasi S Pogoda JM. Botox for migraine: doubleblind, placebo-controlled, region-specific evaluation. Cephalalgia 2000 20 : 421 2.
12. Burch CM Kokoska MS Glaser DA Hollenbeak CS. Treatment of frontal tension headaches with botulinum toxin A. Cephalalgia 2001 21 : 489.
13. Schmitt WJ Slowey E Fravi N Weber S Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001 41 : 658 64.
14. Barrientos N Chana P. Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study. J Headache Pain 2003 4 : 146 51.
15. Schulte-Mattler W Krack P, BoNTTH Study Group. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain 2004 109 : 110 4.
16. Evers S Vollmer-Haase J Schwaag S Rahmann A Husstedt IW Frese A. Botulinum toxin A in the prophylactic treatment of migraine - a randomized, double-blind, placebo-controlled study. Cephalalgia 2004 24 : 838 43.
17. Kokoska MS Glaser DA Burch CM Hollenbeak CS. Botulinum toxin injections for the treatment of frontal tension headache. J Headache Pain 2004 5 : 103 9.
18. Padberg M de Bruijn SFTM de Haan RJ Tavy DLJ. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia 2004 24 : 675 80.
19. Klapper JA Mathew NT Klapper A Kailasam J. Botulinum toxin type A (BTX-A) for the prophylaxis of chronic daily headache. Cephalalgia 2000 20 : 292 3.
20. Freund BJ Schwartz M. Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A. Headache 2002 42 : 1033 7.
21. Schnider P Moraru E Bittner C Vigl M Wöber C Maly J et al. Physical therapy and botulinum toxin type A in patients with cervical associated headache according to IHS-criteria: double-blind placebo-controlled study. Neurology 2001 56 ( Suppl. 3 A349.
22. Göbel H Heinze A Zumbroich V Heinze-Kuhn K. Treatment of coexisting migraine and chronic tension-type headache with botulinum toxin A: a double-blind placebo-controlled study. Cephalalgia 2003 23 : 690.
23. Ondo WG Vuong KD Derman HS. Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia 2004 24 : 60 5.
24. Silberstein SD Stark SR Lucas SM Christie SN Degryse RE Turkel CC. Botulinum toxin type A for the prophylactic treatment of chronic daily hedache: a randomized, doubleblind, placebo-controlled trial. Mayo Clin Proc 2005 80 : 1126 37.